Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Postoperative chemoradiotherapy versus radiotherapy alone for elderly cervical cancer patients with positive margins, lymph nodes, or parametrial invasion.

Cushman TR, Haque W, Menon H, Rusthoven CG, Butler EB, Teh BS, Verma V.

J Gynecol Oncol. 2018 Nov;29(6):e97. doi: 10.3802/jgo.2018.29.e97.

2.

Impact of Enlarged Nonhypermetabolic Lymph Nodes on Outcomes After Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer.

Verma V, Schonewolf CA, Cushman TR, Post CM, Doms A, Berman AT, DeVries M, Katz SI, Simone CB 2nd.

Clin Lung Cancer. 2018 Jul 25. pii: S1525-7304(18)30172-4. doi: 10.1016/j.cllc.2018.07.005. [Epub ahead of print]

PMID:
30111509
3.

The Impact of a 1-Day Multidisciplinary Prostate Cancer Clinic on Patients' Choice of Treatment.

Cushman TR, Mashni J, Roberts T, Kumar R.

J Am Coll Radiol. 2018 Aug 3. pii: S1546-1440(18)30763-4. doi: 10.1016/j.jacr.2018.06.023. [Epub ahead of print] No abstract available.

PMID:
30082231
4.

Overview of ongoing clinical trials investigating combined radiotherapy and immunotherapy.

Cushman TR, Caetano MS, Welsh JW, Verma V.

Immunotherapy. 2018 Aug;10(10):851-0. doi: 10.2217/imt-2018-0019.

PMID:
30073899
5.

Safety of Combined Immunotherapy and Thoracic Radiation Therapy: Analysis of 3 Single-Institutional Phase I/II Trials.

Verma V, Cushman TR, Selek U, Tang C, Welsh JW.

Int J Radiat Oncol Biol Phys. 2018 Aug 1;101(5):1141-1148. doi: 10.1016/j.ijrobp.2018.04.054. Epub 2018 Apr 27.

PMID:
30012526
6.

The effect of early versus delayed radiation therapy on length of hospital stay in the palliative setting.

Cushman TR, Shirvani S, Khan M, Kumar R.

Ann Palliat Med. 2018 May 28. pii: apm.2018.05.07. doi: 10.21037/apm.2018.05.07. [Epub ahead of print]

7.

Comparison of proton therapy and intensity modulated photon radiotherapy for locally advanced non-small cell lung cancer: considerations for optimal trial design.

Cushman TR, Verma V, Rwigema JM.

J Thorac Dis. 2018 Apr;10(Suppl 9):S988-S990. doi: 10.21037/jtd.2018.04.59. No abstract available.

8.

Radiation Followed by OX40 Stimulation Drives Local and Abscopal Antitumor Effects in an Anti-PD1-Resistant Lung Tumor Model.

Niknam S, Barsoumian HB, Schoenhals JE, Jackson HL, Yanamandra N, Caetano MS, Li A, Younes AI, Cadena A, Cushman TR, Chang JY, Nguyen QN, Gomez DR, Diab A, Heymach JV, Hwu P, Cortez MA, Welsh JW.

Clin Cancer Res. 2018 May 21. doi: 10.1158/1078-0432.CCR-17-3279. [Epub ahead of print]

PMID:
29784675
9.

Indoleamine 2,3-dioxygenase 1 inhibition targets anti-PD1-resistant lung tumors by blocking myeloid-derived suppressor cells.

Li A, Barsoumian HB, Schoenhals JE, Cushman TR, Caetano MS, Wang X, Valdecanas DR, Niknam S, Younes AI, Li G, Woodward WA, Cortez MA, Welsh JW.

Cancer Lett. 2018 Sep 1;431:54-63. doi: 10.1016/j.canlet.2018.05.005. Epub 2018 May 8.

PMID:
29746927
10.

Utilization of Neoadjuvant Intensity-modulated Radiation Therapy for Rectal Cancer in the United States.

Cushman TR, Venigalla S, Brooks ED, Lin C, Verma V.

Anticancer Res. 2018 May;38(5):2923-2927.

PMID:
29715118
11.

Combining radiation plus immunotherapy to improve systemic immune response.

Cushman TR, Gomez D, Kumar R, Likacheva A, Chang JY, Cadena AP, Paris S, Welsh JW.

J Thorac Dis. 2018 Feb;10(Suppl 3):S468-S479. doi: 10.21037/jtd.2018.01.130. Review.

12.

Radiation and Anti-Cancer Vaccines: A Winning Combination.

Cadena A, Cushman TR, Anderson C, Barsoumian HB, Welsh JW, Cortez MA.

Vaccines (Basel). 2018 Jan 30;6(1). pii: E9. doi: 10.3390/vaccines6010009. Review.

Supplemental Content

Loading ...
Support Center